I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
de Miguel Luken, Maria J
55
results:
Search for persons
X
Format
Online (55)
Mediatypes
Articles (Online) (37)
OpenAccess-fulltext (18)
Languages
english (45)
spanish (1)
Sorted by: Relevance
Sorted by: Year
?
1
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris III, Howard A.
;
de Miguel Luken, Maria J.
...
Clinical Cancer Research. 28 (2022) 16 - p. 3452-3463 , 2022
Link:
https://doi.org/10.1158/..
?
2
Effect of ceritinib on the pharmacokinetics of coadminister..:
Hurtado, Felipe K.
;
de Braud, Filippo
;
De Castro Carpeño, Javier
...
Cancer Chemotherapy and Pharmacology. 87 (2021) 4 - p. 475-486 , 2021
Link:
https://doi.org/10.1007/..
?
3
Tolerability and antitumor activity of cemiplimab, a human ..:
Moreno, Victor
;
Garrido, Pilar
;
Papadopoulos, Kyriakos P.
...
Lung Cancer. 155 (2021) - p. 151-155 , 2021
Link:
https://doi.org/10.1016/..
?
4
Clinical outcomes and prognostic factors of patients with a..:
Papadatos-Pastos, Dionysis
;
Roda, Desam
;
De Miguel Luken, Maria Jose
...
European Journal of Cancer. 75 (2017) - p. 56-62 , 2017
Link:
https://doi.org/10.1016/..
?
5
A genetic view of laryngeal cancer heterogeneity:
de Miguel-Luken, María José
;
Chaves-Conde, Manuel
;
Carnero, Amancio
Cell Cycle. 15 (2016) 9 - p. 1202-1212 , 2016
Link:
https://doi.org/10.1080/..
?
6
Phosphorylation of gH2AX as a novel prognostic biomarker fo..:
de Miguel-Luken, María José
;
Chaves-Conde, Manuel
;
Quintana, Begoña
...
Oncotarget. 7 (2016) 22 - p. 31723-31737 , 2016
Link:
https://doi.org/10.18632..
?
7
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris, Howard A
;
de Miguel Luken, Maria J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662912/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae
;
Burris, Howard
;
de Miguel Luken, Maria
...
qt6b1472nt. , 2022
Link:
https://escholarship.org..
?
9
MAP17 (PDZKIP1) as a novel prognostic biomarker for larynge..:
de Miguel-Luken, María-José
;
Chaves-Conde, Manuel
;
de Miguel-Luken, Verónica
...
Oncotarget. 6 (2015) 14 - p. 12625-12636 , 2015
Link:
https://doi.org/10.18632..
?
10
Effect of ceritinib on the pharmacokinetics of coadminister..:
Hurtado, Felipe K
;
de Braud, Filippo
;
De Castro Carpeño, Javier
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946667/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
11
Identificación de biomarcadores de cáncer de laringe en pac..:
Miguel Luken, María José de
, 2018
Link:
https://idus.us.es/xmlui..
?
12
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris, Howard A
;
Luken, Maria J. de Miguel
...
Clinical Cancer Research, Vol.28 No.16, pp.3452-3463. , 2022
Link:
https://hdl.handle.net/1..
?
13
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infi..:
Hyman, David M
;
Tran, Ben
;
Paz-Ares, Luis
...
boreal:262133. , 2019
Link:
http://hdl.handle.net/20..
?
14
Phosphorylation of gH2AX as a novel prognostic biomarker fo..:
de Miguel-Luken, María José
;
Chaves-Conde, Manuel
;
Quintana, Begoña
...
http://hdl.handle.net/10668/10071. , 2016
Link:
http://hdl.handle.net/10..
?
15
Phosphorylation of gH2AX as a novel prognostic biomarker fo..:
Miguel-Luken, María José de
;
Chaves-Conde, Manuel
;
Quintana, Begoña
...
Publisher's version. , 2016
Link:
http://hdl.handle.net/10..
1-15
